UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Discontinuation of anti-PD-1 antibody therapy in the absence of disease progression or treatment limiting toxicity: clinical outcomes in advanced melanoma

Annals of oncology, 2019-07, Vol.30 (7), p.1154-1161

2019

Volltextzugriff (PDF)

Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 study

Annals of oncology, 2017-07, Vol.28 (7), p.1631-1639

2017

Volltextzugriff (PDF)

Management of early melanoma recurrence despite adjuvant anti-PD-1 antibody therapy

Annals of oncology, 2020-08, Vol.31 (8), p.1075-1082

2020

Volltextzugriff (PDF)

Assessment of nivolumab exposure and clinical safety of 480 mg every 4 weeks flat-dosing schedule in patients with cancer

Annals of oncology, 2018-11, Vol.29 (11), p.2208-2213

2018

Volltextzugriff (PDF)

Circulating tumour DNA predicts response to anti-PD1 antibodies in metastatic melanoma

Annals of oncology, 2017-05, Vol.28 (5), p.1130-1136

2017

Volltextzugriff (PDF)

Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab

Annals of oncology, 2017-02, Vol.28 (2), p.368-376

2017

Volltextzugriff (PDF)

Safety of resuming anti-PD-1 in patients with immune-related adverse events (irAEs) during combined anti-CTLA-4 and anti-PD1 in metastatic melanoma

Annals of oncology, 2018-01, Vol.29 (1), p.250-255

2018

Volltextzugriff (PDF)

Use of Severity Grades to Characterize Histopathologic Changes

Toxicologic pathology, 2018-04, Vol.46 (3), p.256-265

2018

Volltextzugriff (PDF)

Survival update of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma in the OpACIN and OpACIN-neo trials

Annals of oncology, 2023-04, Vol.34 (4), p.420-430

2023

Volltextzugriff (PDF)

FDG-PET to predict long-term outcome from anti-PD-1 therapy in metastatic melanoma

Annals of oncology, 2022-01, Vol.33 (1), p.99-106

2022

Volltextzugriff (PDF)

Targeting BRAF for patients with melanoma

British journal of cancer, 2011-02, Vol.104 (3), p.392-398

2011

Volltextzugriff (PDF)

FDG-PET response and outcome from anti-PD-1 therapy in metastatic melanoma

Annals of oncology, 2018-10, Vol.29 (10), p.2115-2120

2018

Volltextzugriff (PDF)

Functional cell phenotype induction with TGF-β1 and collagen-polyurethane scaffold for annulus fibrosus rupture repair

European Cells and Materials, 2020-01, Vol.39, p.1-17

2020

Volltextzugriff (PDF)

Efficacy of immune checkpoint inhibitors for the treatment of advanced melanoma in patients with concomitant chronic lymphocytic leukemia

Annals of oncology, 2023-09, Vol.34 (9), p.796-805

2023

Volltextzugriff (PDF)

Pathological assessment of resection specimens after neoadjuvant therapy for metastatic melanoma

Annals of oncology, 2018-08, Vol.29 (8), p.1861-1868

2018

Volltextzugriff (PDF)

Cutaneous manifestations of dabrafenib (GSK2118436): a selective inhibitor of mutant BRAF in patients with metastatic melanoma

British journal of dermatology (1951), 2012-11, Vol.167 (5), p.1153-1160

2012

Volltextzugriff (PDF)

Correlation of BRAF and NRAS mutation status with outcome, site of distant metastasis and response to chemotherapy in metastatic melanoma

British journal of cancer, 2014-07, Vol.111 (2), p.292-299

2014

Volltextzugriff (PDF)

Thermoresponsive, redox-polymerized cellulosic hydrogels undergo in situ gelation and restore intervertebral disc biomechanics post discectomy

European Cells and Materials, 2018-05, Vol.35, p.300-317

2018

Volltextzugriff (PDF)

A Systematic Review of the Application And Correlates of YFAS-Diagnosed ‘Food Addiction' in Humans: Are Eating-Related ‘Addictions' a Cause for Concern or Empty Concepts?

Obesity facts, 2015-01, Vol.8 (6), p.386-401

2015

Volltextzugriff (PDF)

Atrophic exocrine pancreatic insufficiency associated with anti-PD1 therapy

Annals of oncology, 2017-02, Vol.28 (2), p.434-435

2017

Volltextzugriff (PDF)

Effect of nivolumab on health-related quality of life in patients with treatment-naïve advanced melanoma: results from the phase III CheckMate 066 study

Annals of oncology, 2016-10, Vol.27 (10), p.1940-1946

2016

Volltextzugriff (PDF)

Pre-operative ctDNA predicts survival in high-risk stage III cutaneous melanoma patients

Annals of oncology, 2019-05, Vol.30 (5), p.815-822

2019

Volltextzugriff (PDF)

Histopathological features of complete pathological response predict recurrence-free survival following neoadjuvant targeted therapy for metastatic melanoma

Annals of oncology, 2020-11, Vol.31 (11), p.1569-1579

2020

Volltextzugriff (PDF)

Design Requirements for Annulus Fibrosus Repair: Review of Forces, Displacements, and Material Properties of the Intervertebral Disk and a Summary of Candidate Hydrogels for Repair

Journal of biomechanical engineering, 2016-02, Vol.138 (2), p.021007

2016

Volltextzugriff (PDF)

Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy

British journal of cancer, 2016-05, Vol.114 (10), p.1084-1089

2016

Volltextzugriff (PDF)

1 – 25 von 4.388

Suche als RSS-Feed

Aktive Filter

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(3.962)
Mit Volltextzugriff
(3.329)

Publikationsform

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(3.624)
Life Sciences & Biomedicine
(3.416)
Female
(2.072)
Male
(1.948)
Adult
(1.335)
Middle Aged
(1.270)
Biological And Medical Sciences
(1.264)
Medical Sciences
(1.066)
Aged
(917)
Animals
(736)
Adolescent
(533)
Oncology
(454)
Child
(416)
Mice
(337)
General & Internal Medicine
(333)
Aged, 80 And Over
(311)
Treatment Outcome
(309)
Surgery
(299)
Fundamental And Applied Biological Sciences. Psychology
(283)

14 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(4.361)
EZB Electronic Journals Library
(2.131)
Journals@Ovid
(2.010)
IngentaConnect Journals
(1.826)
Publisher website
(1.298)
Elsevier ScienceDirect Journals Complete
(926)
IngentaConnect Journals
(640)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(603)
Wiley Online Library
(527)
Wiley Online Library Full Collection 2018
(395)
Oxford journals
(275)
SpringerLink Journals (MCLS)
(242)
Oxford Journals 2020 Medicine
(219)
Springer Nature - Connect here FIRST to enable access
(212)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(158)
JSTOR
(156)
Nexis Uni
(122)
SAGE Publications
(121)
EBSCOhost Psychology and Behavioral Sciences Collection
(115)
Taylor & Francis Journals
(107)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Discontinuation of anti-PD-1 antibody therapy in the absence of disease progression or treatment limiting toxicity: clinical outcomes in advanced melanoma

Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 study

Management of early melanoma recurrence despite adjuvant anti-PD-1 antibody therapy

Assessment of nivolumab exposure and clinical safety of 480 mg every 4 weeks flat-dosing schedule in patients with cancer

Circulating tumour DNA predicts response to anti-PD1 antibodies in metastatic melanoma

Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab

Safety of resuming anti-PD-1 in patients with immune-related adverse events (irAEs) during combined anti-CTLA-4 and anti-PD1 in metastatic melanoma

Use of Severity Grades to Characterize Histopathologic Changes

Survival update of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma in the OpACIN and OpACIN-neo trials

FDG-PET to predict long-term outcome from anti-PD-1 therapy in metastatic melanoma

Targeting BRAF for patients with melanoma

FDG-PET response and outcome from anti-PD-1 therapy in metastatic melanoma

Functional cell phenotype induction with TGF-β1 and collagen-polyurethane scaffold for annulus fibrosus rupture repair

Efficacy of immune checkpoint inhibitors for the treatment of advanced melanoma in patients with concomitant chronic lymphocytic leukemia

Pathological assessment of resection specimens after neoadjuvant therapy for metastatic melanoma

Cutaneous manifestations of dabrafenib (GSK2118436): a selective inhibitor of mutant BRAF in patients with metastatic melanoma

Correlation of BRAF and NRAS mutation status with outcome, site of distant metastasis and response to chemotherapy in metastatic melanoma

Thermoresponsive, redox-polymerized cellulosic hydrogels undergo in situ gelation and restore intervertebral disc biomechanics post discectomy

A Systematic Review of the Application And Correlates of YFAS-Diagnosed ‘Food Addiction' in Humans: Are Eating-Related ‘Addictions' a Cause for Concern or Empty Concepts?

Atrophic exocrine pancreatic insufficiency associated with anti-PD1 therapy

Effect of nivolumab on health-related quality of life in patients with treatment-naïve advanced melanoma: results from the phase III CheckMate 066 study

Pre-operative ctDNA predicts survival in high-risk stage III cutaneous melanoma patients

Histopathological features of complete pathological response predict recurrence-free survival following neoadjuvant targeted therapy for metastatic melanoma

Design Requirements for Annulus Fibrosus Repair: Review of Forces, Displacements, and Material Properties of the Intervertebral Disk and a Summary of Candidate Hydrogels for Repair

Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy

Aktive Filter

Suchergebnisse filtern